EyePoint Pharmaceuticals(EYPT)
搜索文档
EyePoint Pharmaceuticals(EYPT) - 2019 Q2 - Earnings Call Transcript
2019-08-08 00:46
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q2 2019 Earnings Conference Call August 7, 2019 8:30 AM ET Company Participants Kimberly Minarovich - Investor Relations, Argot Partners Nancy Lurker - President & Chief Executive Officer Scott Jones - Chief Commercial Officer Conference Call Participants Andrew D’Silva - B. Riley FBR Yi Chen - H.C. Wainwright Operator Good morning. My name is Lynch, and I will be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharm ...
Eyepoint Pharmaceuticals (EYPT) Investor Presentation - Slideshow
2019-06-07 03:33
Delivering Innovative Ophthalmic Products to Patients with Serious Eye Disorders Investor Presentation June 2019 NASDAQ: EYPT Forward Looking SAFE HARBOR STATEMENTS UNDER THE PRIVATE SECURITIES LITIGATION ACT OF 1995: Various statements made in this release are forward-looking, and are inherently subject to risks, uncertainties and potentially inaccurate assumptions. This presentation is intended for communication for investors only. Nothing in this presentation should be construed as promoting the use of D ...
EyePoint Pharmaceuticals(EYPT) - 2019 Q1 - Quarterly Report
2019-05-11 04:07
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | --- | --- | |-------------------------------------------------------------------------------------------------------|----------------------------- ...
EyePoint Pharmaceuticals(EYPT) - 2019 Q1 - Earnings Call Transcript
2019-05-09 02:36
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q1 2019 Earnings Conference Call May 8, 2019 8:30 AM ET Company Participants David Price - CFO Nancy Lurker - President and CEO Conference Call Participants Andrew D'Silva - B. Riley FBR Yi Chen - H.C. Wainwright Operator Good morning. My name is Skyler, and I will be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharmaceuticals' first quarter 2019 financial results conference call. There will be a question and ans ...